amylin
Amycretin tracker
Educational reference for Amycretin. Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
—
Tmax
—
Category
amylin
Also known as: amycretin-sc, amycretin-oral
Amycretin is an investigational amylin and GLP-1 receptor co-agonist.
Mechanism
An investigational single-molecule agonist of both the amylin and GLP-1 receptors, in subcutaneous and oral forms.
Research summary
Phase 1b/2a data for the subcutaneous form were published in The Lancet in 2025. Not FDA-approved.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Amycretin phase 1b/2a subcutaneous trial · The Lancet (2025)No verified human half-life was located in public summaries, so none is shown.
TrackPep est un outil de suivi. Il enregistre ce que vous saisissez et ne recommande ni ne calcule jamais de quantités.